TRIGLIDE patient counseling information
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Patient Counseling Information
Patients should be advised:
- of the potential benefits and risks of Triglide.
- not to use Triglide if there is a known hypersensitivity to fenofibrate or fenofibric acid.
- of medications that should not be taken in combination with Triglide.
that if they are taking coumarin anticoagulants, Triglide may increase their anti-coagulant effect, and increased monitoring may be necessary.
- to inform their physician of all medications, supplements, and herbal preparations they are taking and any change in their medical condition.
- to inform a physician prescribing a new medication, that they are taking Triglide.
- to continue to follow an appropriate lipid-modifying diet while taking Triglide.
- to take Triglide once daily at the prescribed dose, swallowing each tablet whole.
- to inform their physician of any muscle pain, tenderness, or weakness; onset of abdominal pain; or any other new symptoms.
- to return to their physician’s office for routine monitoring.
Distributed by: Shionogi Inc. Florham Park, NJ 07932
Manufactured by: Aenova France SAS, 38291 Saint-Quentin-Fallavier, France
Made in France
TRI-PI-03
Rev. 01/2013
© Shionogi Inc. All rights reserved.[1]
Manufactured for:
Lupin Pharma
Baltimore, Maryland 21202
United States.
Manufactured by:
Lupin Limited
Goa - 403 722
INDIA.
Address Medical Inquiries to:
Lupin Pharma Medical Inquiries
111 South Calvert Street, 21st Floor
Baltimore, MD 21202
or Call: 1-800-399-2561
October 2013 ID: 235480[2]
References
- ↑ "TRIGLIDE (FENOFIBRATE) TABLET [SHIONOGI INC.]". Retrieved 12 February 2014.
- ↑ "ANTARA (FENOFIBRATE) CAPSULE [LUPIN PHARMA]". Retrieved 12 February 2014.